We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Notice for valoctocogene roxaparvovec (BioMarin Pharmaceuticals Australia Pty Ltd)
Active ingredients
valoctocogene roxaparvovec
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Intravenous Infusion
Indication
Treatment of haemophilia A
Therapeutic area
Haematology